GA-ASI Makes Another Autonomous Aerial Intercept in Company-Funded Demo with MQ-20 Avenger(R) 
Asian Financial Forum opens next Monday as the region’s first major international financial event of 2026 
Building the data infrastructure for next-generation materials science 
Ynvisible Interactive Inc. Marks Start of 2026 with Commercial Momentum Built in 2025 and Clear Execution Path Forward 
Seline Introduces Conversational Analytics to Simplify How Teams Understand Their Data Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care, supported by Helsinn, awarded to Patrick Johnson, MD
Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care, supported by Helsinn, awarded to…
SELLAS Reports Encouraging Updated Clinical Data from Ongoing Mesothelioma Study of Galinpepimut-S (GPS) Combined with Opdivo
Updated Data Show Median Overall Survival of 35.4 Weeks in Patients Treated With Combination Therapy…
Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539
– Phase 1b expansion cohorts designed to enable refinement of recommended Phase 2 dose –…
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of…
Novan Announces Inclusion in Russell Microcap® Index
DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites
Salted Caramel Pretzel Bites by Bogart’s Kitchen TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Aleafia…
Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry
Co-founder and Chief Scientific Officer of Optinose AS honored for his invention of the technology…
Aerami Therapeutics Initiates Dosing in Phase 1 Trial of AER-901, Its Proprietary Inhaled Imatinib for the Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) affects almost 68,000 patients worldwide, with treatment limited to vasodilators, none…
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film
Anticipates FDA PDUFA goal date in late 2021 If approved by the FDA for US…
Selecta Biosciences Appoints Industry Leader Nishan de Silva, M.D. to Board of Directors
WATERTOWN, Mass., June 24, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company…
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer
Provides Compelling Rationale for the Upcoming Phase 2b Clinical Study in Patients with Poor Response…
Corsair Pharma, Inc. to Host Key Opinion Leader Meeting on Pulmonary Arterial Hypertension
SOUTH SAN FRANCISCO, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Corsair Pharma, Inc., a private…
Monopar to Present Results from Analysis of Oropharyngeal Cancer Patients in Completed Phase 2 Validive® Trial at MASCC/ISOO
WILMETTE, Ill., June 24, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
Albireo to Present at Piper Sandler’s Virtual EASL Takeaway Day
BOSTON, June 24, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver…
BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies
VANCOUVER, British Columbia, June 24, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Brickell Biotech Announces Initiation of a Phase 1 Study of Sofpironium Bromide Gel in Primary Palmoplantar Hyperhidrosis Patients by its Development Partner, Kaken Pharmaceutical in Japan
BOULDER, Colo., June 24, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell” or the “Company”)…
Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer’s Disease Trial Accepted for Developing Topics Presentation at the 2021 Annual Alzheimer’s Association International Conference
Abstract presentation highlights safety and potential efficacy of Lomecel-B infusion in patients with mild Alzheimer’s…
BioVie Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites
SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or…
QuestionPro Survey Finds Two-Thirds of Americans Believe in UFOs
They also believe the government is not telling them everything AUSTIN, Texas, June 24, 2021…
Logiq Launches New Audio Digital Marketing Channel for Agencies and Brands
NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a…